title: Improved peripheral perfusion during endothelin--a receptor blockade in patients with type 2 diabetes and critical limb ischemia.
authors.forename: Majid
authors.initials: M
authors.lastname: Kalani
authors.forename: John
authors.initials: J
authors.lastname: Pernow
authors.forename: Joakim
authors.initials: J
authors.lastname: Bragd
authors.forename: Gun
authors.initials: G
authors.lastname: Jörneskog
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D065130:Endothelin A Receptor Antagonists; D006801:Humans; D007511:Ischemia / Q000188:drug therapy; D007866:Leg / Q000098:blood supply; D008833:Microcirculation; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D016491:Peripheral Vascular Diseases; D013599:Systole / Q000187:drug effects
chemical_list: D000959:Antihypertensive Agents; D065130:Endothelin A Receptor Antagonists; D010456:Peptides, Cyclic; C072247:cyclo(Trp-Asp-Pro-Val-Leu)